LOL. Yes good point but I was thinking of Linda's price at $20B+ in the next six months to year would be considered "fully valued" at that point. I still think that most people believe that the development of DCVax would more robust in the hands of Merck. Thinking more about a partnership with Northwest leading the development leads me to believe that Merck would much rather take the whole company and control of development.